Transverse Medical Inc.
Transverse Medical Inc. is a medical device company dedicated to developing the POINT-GUARD™ Cerebral Embolic Protection device. Their mission is to reduce and eliminate the risk of procedural stroke during cardiovascular procedures by providing maximum cerebral coverage and protection from embolic debris, thereby improving patient outcomes and reducing healthcare costs. Their vision is to ensure that operative and interventional procedures of the heart are without risk of stroke or unnecessary complications.
Industries
Nr. of Employees
small (1-50)
Transverse Medical Inc.
Golden, Colorado, United States, North America
Products
Full‑brain cerebral embolic protection device (catheter‑delivered filter system)
A catheter‑delivered filter system designed to provide maximum coverage of cerebral arch vessels and capture embolic debris during cardiovascular and structural heart procedures to reduce periprocedural stroke risk.
Full‑brain cerebral embolic protection device (catheter‑delivered filter system)
A catheter‑delivered filter system designed to provide maximum coverage of cerebral arch vessels and capture embolic debris during cardiovascular and structural heart procedures to reduce periprocedural stroke risk.
Services
Sponsor and execution of feasibility clinical studies
Design and conduct of feasibility / first‑in‑human clinical studies for cerebral embolic protection devices in structural heart procedures.
Medical device R&D and engineering
Device concept development, simulation (FEA/CFD), prototyping, and engineering to produce catheter‑based embolic protection systems.
Regulatory, clinical affairs and quality program leadership
Development and management of regulatory strategies, submission preparation, and quality systems implementation to support device development and approvals.
Sponsor and execution of feasibility clinical studies
Design and conduct of feasibility / first‑in‑human clinical studies for cerebral embolic protection devices in structural heart procedures.
Medical device R&D and engineering
Device concept development, simulation (FEA/CFD), prototyping, and engineering to produce catheter‑based embolic protection systems.
Regulatory, clinical affairs and quality program leadership
Development and management of regulatory strategies, submission preparation, and quality systems implementation to support device development and approvals.
Expertise Areas
- Cerebral embolic protection device development
- Structural heart and TAVR procedural risk mitigation
- Clinical trial management and feasibility study execution
- Medical device regulatory strategy and submissions
Key Technologies
- Filter‑based cerebral embolic protection
- Catheter‑delivered endovascular devices
- Finite Element Analysis (FEA)
- Computational Fluid Dynamics (CFD)